INMED PHARMACEUTICALS INC. (INM) Free cash flow 2020–2025
INMED PHARMACEUTICALS INC. (INM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$7.8MFY2025 · since FY2020: -$7.4M → -$7.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$7.8M | -11.0% |
| FY2024 | -$7.0M | +6.0% |
| FY2023 | -$7.4M | +52.4% |
| FY2022 | -$15.6M | -59.5% |
| FY2021 | -$9.8M | -32.0% |
| FY2020 | -$7.4M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice